William R. Rohn

William R. Rohn

Direktor/Vorstandsmitglied bei
La Jolla Institute for Allergy & Immunology
82 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

William R.
Rohn
is currently the Director at La Jolla Institute for Allergy & Immunology.
He was formerly the Chairman at Pfenex, Inc. from 2014 to 2017, Non-Executive Director at Elan Corp.
Plc from 2009 to 2010, Independent Director at Cerus Corp.
from 2011 to 2011, Independent Director at Sophiris Bio, Inc. from 2011 to 2014, Director at Metabasis Therapeutics, Inc. from 2004 to 2010, Director at Raven Biotechnologies, Inc. from 2005 to 2010, and Chief Operating Officer at Biogen, Inc. from 2003 to 2005.
He was also the President & Chief Operating Officer at IDEC Pharmaceuticals Corp.
from 1993 to 2003 and Senior Vice President-Sales & Marketing at Adria Laboratories from 1984 to 1993.
Mr. Rohn received his undergraduate degree from Michigan State University.

Aktive Positionen von William R. Rohn

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 23.06.2011

Ehemalige bekannte Positionen von William R. Rohn

UnternehmenPositionEnde
PFENEX INC. Vorsitzender 05.05.2017
SOPHIRIS BIO Direktor/Vorstandsmitglied 01.04.2014
CERUS CORPORATION Direktor/Vorstandsmitglied 27.06.2011
Direktor/Vorstandsmitglied 19.04.2010
Direktor/Vorstandsmitglied 28.01.2010
Sehen Sie sich die Erfahrung von William R. Rohn im Detail an

Ausbildung von William R. Rohn

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

65

Beziehungen ersten Grades

17

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen17

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Consumer Services

Health Technology

Health Technology

Adria Laboratories

Commercial Services

Health Technology

  1. Börse
  2. Insiders
  3. William R. Rohn